Back to search

Sporegen Limited

08001035

active
ltd
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
Incorporated 22/03/2012

Previously known as

Holloway Immunology Ltd · until 19/12/2013

Compliance

Last accounts

31/03/2025

total exemption full

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 23/11/2025

Due 07/12/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Simon Michael Cutting

director · Since 22/03/2012

British · United Kingdom · Age 64

Former

Joanna Ruth Cox

director · Resigned 13/03/2013

Paul Jonathan Hogg

director · Resigned 18/01/2017

Stephen Peter Yeates

director · Resigned 18/01/2017

Tony Greewood

director · Resigned 18/01/2017

James Cowper Trustees Limited

corporate secretary · Resigned 19/04/2018

Persons with Significant Control

Dr Simon Michael Cutting

25–50% shares
25–50% votes

British · United Kingdom · Age 64

The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH

Notified 06/04/2016

Change History

statusactive
2026-06-06

Active

typeltd
2026-06-06

Private Limited Company

address line1The London Bioscience Innovation Centre
2026-06-06

THE LONDON BIOSCIENCE INNOVATION CENTRE

post townLondon
2026-06-06

LONDON

officer appointedCUTTING, Simon Michael, Dr
2026-06-06

CompanyRankvs 83+ SIC 72110 peers
84

Financial strength91th percentile among SIC peers · 23/25
Employees82th percentile among SIC peers · 12/15
LiquidityCurrent ratio 21.09× · 20/20
Longevity14 years trading (max 15) · 14/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity14/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£815k

Balance sheet strength

Cash

£561k

Cash in the bank

Net Current Assets

£611k

Working capital

Current Assets

£641k

Current Liabilities

£30k

Fixed Assets

£208k

Debtors

£81k

4avg. employees

Tax at Year End(2019)

Corp tax£13k

Balance Sheet

Intangible assets£193k
Assets less current liabilities£819k
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
202521.09-£27k
202435.90+£15k
2023153.51-£140k
202214.85+£163k
20219.64+£305k
202017.19+£138k
20195.22

Derived from filed accounts. Not audited figures.